Loading...
Loading...
Akebia
Therapeutics, Inc.
AKBA announced Wednesday, the pricing of an
underwritten public offering of 7,250,000 shares of common stock at a
price to the public of $9.00 per share. In addition, Akebia has granted
the underwriters a 30-day option to purchase up to an additional
1,087,500 shares of common stock in connection with the offering. All
shares are being sold by Akebia. The net proceeds of the offering are
expected to be approximately $61.0 million (or approximately $70.2
million if the underwriters exercise their option to purchase additional
shares in full), after deducting underwriting discounts and commissions
and other estimated offering expenses payable by Akebia. The offering is
expected to close on January 12, 2016, subject to the satisfaction of
See full press release© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in